Compounds for treatment of angiogenesis-mediated diseases

US10738024B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10738024-B2
Application numberUS-201414888117-A
CountryUS
Kind codeB2
Filing dateMay 6, 2014
Priority dateMay 6, 2013
Publication dateAug 11, 2020
Grant dateAug 11, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Synthetic cremastranone and cremastranone analogs are disclosed. Additionally, methods for synthesizing cremastranone and cremastranone analogs are disclosed. Methods of treating ocular neovascularization disorders and treating angiogenesis-mediated disease are also disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A synthetic compound comprising formula (I) wherein R 1 is selected from the group consisting of hydroxyl and alkoxy, R 2 is selected from the group consisting of hydroxyl, alkoxy, substituted alkoxy, alkyl carbonyloxy, substituted alkyl carbonyloxy, alkyl carbonyl, substituted alkyl carbonyl, aryl carbonyloxy, substituted aryl carbonyloxy, halogen, amino, nitro, hydrocarbyl and substituted hydrocarbyl; R 3 is selected from the group consisting of hydroxyl and alkoxy; R 4 is independently selected from the group consisting of hydroxyl, alkoxy, substituted alkoxy, alkyl carbonyloxy, substituted alkyl carbonyloxy, alkyl carbonyl, substituted alkyl carbonyl, aryl carbonyloxy, substituted aryl carbonyloxy, halogen, amino, nitro, hydrocarbyl and substituted hydrocarbyl; R 5 is independently selected from the group consisting of hydrogen, alkoxy, substituted alkoxy, alkyl carbonyloxy, substituted alkyl carbonyloxy, alkyl carbonyl, aryl carbonyloxy, substituted aryl carbonyloxy, halogen, amino, nitro, hydrocrabyl and substituted hydrocarbyl; X is selected from the group consisting of CH, nitrogen, and Y, and Z are independently selected from the group consisting of CH 2 , nitrogen, and oxygen, wherein when R 1 is hydroxyl and R 2 is an alkoxy, R 3 is not hydroxy. 2. The synthetic compound selected from the group consisting of .

Assignees

Inventors

Classifications

  • a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring · CPC title

  • condensed with one six-membered ring · CPC title

  • Ortho-condensed systems · CPC title

  • Oxygen atoms · CPC title

  • containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10738024B2 cover?
Synthetic cremastranone and cremastranone analogs are disclosed. Additionally, methods for synthesizing cremastranone and cremastranone analogs are disclosed. Methods of treating ocular neovascularization disorders and treating angiogenesis-mediated disease are also disclosed.
Who is the assignee on this patent?
Univ Indiana Res & Tech Corp, Gachon Univ Of Industry-Academic Cooperation Foundation
What technology area does this patent fall under?
Primary CPC classification C07D311/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).